New eye injection aims to halt blinding disease in seniors
Disease control
Ongoing
This study is testing if a new drug called ANX007, given as a monthly injection into the eye, can slow down vision loss in people with geographic atrophy, a late-stage form of age-related macular degeneration. About 660 participants will be randomly assigned to receive either the…
Phase: PHASE3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC